64 results
8-K
EX-99.1
DMTK
DermTech Inc
2 Nov 23
Dermtech Reports Third-quarter 2023 Financial Results
4:09pm
technology, today reported its third-quarter 2023 financial results.
“We’re just a few months into our strategy of prioritizing reimbursed tests
8-K
EX-99.1
DMTK
DermTech Inc
11 Sep 23
Dermtech Appoints Mark Aguillard As Chief Commercial Officer
8:10am
Aguillard as chief commercial officer effective September 19, 2023. Mr. Aguillard will lead DermTech’s overall commercial strategy and execution.
Commenting
DEFA14A
DMTK
DermTech Inc
9 May 23
Additional proxy soliciting materials
4:03pm
strategy to fully capitalize on commercializing its genomic products and executing against its many growth opportunities. The board looks forward
8-K
EX-99.1
DMTK
DermTech Inc
9 May 23
Dermtech Appoints Bret Christensen As New President and Ceo
8:30am
in the diagnostics industry align with DermTech’s strategy to fully capitalize on commercializing its genomic products and executing against its many
424B5
iadu1
17 Aug 22
Prospectus supplement for primary offering
4:23pm
424B5
hu97nixjhzvw
7 Jan 21
Prospectus supplement for primary offering
4:26pm
424B5
ovs58g
6 Jan 21
Prospectus supplement for primary offering
4:06pm
424B3
n8mknip5v9bz6
12 Nov 20
Prospectus supplement
12:00am
424B3
1qapj
12 Nov 20
Prospectus supplement
12:00am
424B5
c7f1fpz07e09rze n8
10 Nov 20
Prospectus supplement for primary offering
5:01pm
POS AM
zq3n408
5 Nov 20
Prospectus update (post-effective amendment)
5:13pm
POS AM
2gzypg7 wxc
5 Nov 20
Prospectus update (post-effective amendment)
5:13pm